Clinical Trial Update: Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma [Phase 1]

View source ↗

Summary

Phase 1 study of transfected dendritic cell–based therapy in patients with breast cancer or malignant melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Malignant Melanoma

Drugs mentioned

• Transfected dendritic cell-based therapy

Snippet

Sponsor: Inge Marie Svane | Conditions: Breast Cancer, Malignant Melanoma | Phase 1 | Status: COMPLETED